Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.ASTH · Entity 4538 | Director | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,188 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 4,525 · Balance 18,188 F1: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. F2: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
F2: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MARVELL TECHNOLOGY GROUP LTD
Report date October 24, 2017 · Filed October 25, 2017
Jointly reported with Sutardja, Sehat
Section 16 reporting ended · disclosed 2017-10-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | IndirectBy Sutardja Family LLC | 7,199,378 |
Reported balance
After 2017-10-24 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-10-24 · Sale · Disposed 6,059,353 · Balance 7,199,378 F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.59, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company. |
| Common SharesSEC Table I · non-derivative | IndirectBy SSWD LLC | 39,832,511 |
Reported balance
Holding disclosure · report date 2017-10-24 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 39,832,511 F2: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F4: Ms. Dai and Dr. Sutardja are the managing members of the SSWD LLC, a Delaware limited liability company. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.59, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.
F2: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife.
F3: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company.
F4: Ms. Dai and Dr. Sutardja are the managing members of the SSWD LLC, a Delaware limited liability company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 20:16 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 4,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-073475 · tm2617575-2_4seq1.xml · nonDerivative · entry 1 Dai, Weili · CIK 0001134140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,188 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. F2 · balance_after: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:18 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 6,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-059372 · tm2517874-3_4seq1.xml · nonDerivative · entry 1 Dai, Weili · CIK 0001134140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,663 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. F2 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 20:37 UTC | Astrana Health, Inc. ASTH · Entity 4538 | GrantCommon Stock | 3,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-089694 · tm2421691-4_4seq1.xml · nonDerivative · entry 1 Dai, Weili · CIK 0001134140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,214 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) August 13, 2025 or (ii) the date of the Issuer's 2025 annual meeting of stockholders. F2 · balance_after: Includes 3,650 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 00:54 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 3,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-127015 · tm2333076-2_4seq1.xml · nonDerivative · entry 1 Dai, Weili · CIK 0001134140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors). F2 · balance_after: Includes 3,650 shares of restricted stock, which will vest on December 9, 2024. Read SEC document |
| October 24, 2017 Filed Oct 25, 2017 21:26 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 6,059,353 | $18.56 | $112,446,443.30 |
DisclosureSEC source: 0001140361-17-039604 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 7,199,378 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.59, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| October 23, 2017 Filed Oct 24, 2017 17:53 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 1,204,161 | $18.55 | $22,338,149.88 |
DisclosureSEC source: 0001140361-17-039448 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 13,258,731 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.88, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| October 20, 2017 Filed Oct 24, 2017 17:53 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 62,337 | $18.48 | $1,152,025.16 |
DisclosureSEC source: 0001140361-17-039448 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 14,462,892 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.47 to $18.50, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 16:19 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 474,771 | $18.48 | $8,774,337.81 |
DisclosureSEC source: 0001140361-17-039176 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 14,525,229 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.45 to $18.52, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| October 12, 2017 Filed Oct 13, 2017 16:12 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 30,091 | $18.48 | $556,165.93 |
DisclosureSEC source: 0001140361-17-038652 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 36,363,616 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.48 to $18.49, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 16:12 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 1,394,728 | $18.52 | $25,833,152.02 |
DisclosureSEC source: 0001140361-17-038652 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 36,393,707 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.55, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| October 10, 2017 Filed Oct 11, 2017 17:27 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 1,687,118 | $18.49 | $31,202,572.56 |
DisclosureSEC source: 0001140361-17-038323 · doc1.xml · nonDerivative · entry 3 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 37,788,435 F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $18.54, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 6 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F5 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 17:27 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 570,000 | $18.47 | $10,529,838.00 |
DisclosureSEC source: 0001140361-17-038323 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 39,475,553 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.44 to $18.53, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F5 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 17:27 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 470,692 | $18.49 | $8,700,835.76 |
DisclosureSEC source: 0001140361-17-038323 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 15,000,000 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.36 to $18.54, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| October 04, 2017 Filed Oct 6, 2017 21:19 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 387,642 | $18.48 | $7,164,515.74 |
DisclosureSEC source: 0001140361-17-037840 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 15,470,692 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $18.54, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the Sutardja Family, a Delaware limited liability company. Read SEC document |
| October 03, 2017 Filed Oct 4, 2017 17:35 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 420,000 | $18.50 | $7,770,714.00 |
DisclosureSEC source: 0001140361-17-037662 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 15,858,334 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.41 to $18.59, inclusive. The reporting person undertakes to provide Marvell Marvel, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 17:35 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 1,422,500 | $18.52 | $26,348,398.50 |
DisclosureSEC source: 0001140361-17-037662 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 16,278,334 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $18.71, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 16:38 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 90,405 | $18.02 | $1,629,089.06 |
DisclosureSEC source: 0001140361-17-037124 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 40,045,553 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.07, inclusive. The reporting person undertakes to provide Marvell Marvel, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 28, 2017 Filed Oct 2, 2017 16:38 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 3,490 | $18.01 | $62,846.18 |
DisclosureSEC source: 0001140361-17-037124 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 40,135,958 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.05, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 16:23 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 252,500 | $18.57 | $4,688,975.50 |
DisclosureSEC source: 0001140361-17-035916 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 17,700,834 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $18.66, inclusive. The reporting person undertakes to provide Marvell Marvel, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 16:23 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 300,000 | $18.49 | $5,547,390.00 |
DisclosureSEC source: 0001140361-17-035916 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Sutardja Family LLC Disclosed balance after: 17,953,334 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.45 to $18.54, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of the Sutardja Family LLC, a Delaware limited liability company. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 16:08 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 375,000 | $18.13 | $6,798,487.50 |
DisclosureSEC source: 0001140361-17-035668 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 40,139,448 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.87 to $18.37, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 16:08 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 1,000,000 | $17.73 | $17,734,900.00 |
DisclosureSEC source: 0001140361-17-035668 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 40,514,448 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.60 to $17.87, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 17:09 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 550,000 | $17.50 | $9,622,470.00 |
DisclosureSEC source: 0001140361-17-035356 · doc1.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 41,514,448 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.42 to $17.61, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 17:09 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 492,343 | $17.41 | $8,573,168.66 |
DisclosureSEC source: 0001140361-17-035356 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 42,064,448 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.38 to $17.445, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 16:24 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 537,235 | $17.57 | $9,439,057.78 |
DisclosureSEC source: 0001140361-17-035044 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 42,556,761 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.49 to $17.67, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 17:08 UTC Amendment | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 537,235 | $17.57 | $9,439,057.78 |
DisclosureSEC source: 0001140361-17-035355 · doc1.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 42,556,791 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.49 to $17.67, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvel"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 16:28 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 120,422 | $17.82 | $2,145,763.49 |
DisclosureSEC source: 0001209191-17-051876 · doc4.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 43,094,026 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.70 to $17.925, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 16:28 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 300,000 | $17.84 | $5,352,810.00 |
DisclosureSEC source: 0001209191-17-051876 · doc4.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SSWD LLC Disclosed balance after: 43,214,448 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.82 to $17.87, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. F2 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. F3 · ownership.nature: Ms. Dai and Dr. Sutardja are the managing members of SSWD LLC, a Delaware limited liability company. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 226,800 | $0.00 Strike: $14.01 | $0.00 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · derivative · entry 11 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 226,800 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 28, 2007, the vesting commencement date. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 235,000 | $0.00 Strike: $14.01 | $0.00 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · derivative · entry 10 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 235,000 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 28, 2007, the vesting commencement date. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 272,882 | $0.00 Strike: $10.76 | $0.00 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · derivative · entry 9 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 272,882 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of April 30, 2013, the vesting commencement date. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 226,800 | $14.22 | $3,225,141.36 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · nonDerivative · entry 6 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 226,800 | $14.01 | $3,177,468.00 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · nonDerivative · entry 5 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,695,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 235,000 | $14.22 | $3,341,747.00 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · nonDerivative · entry 4 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.18 to $14.315, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 235,000 | $14.01 | $3,292,350.00 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · nonDerivative · entry 3 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,703,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 272,882 | $14.13 | $3,855,467.91 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.08 to $14.22, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 09:02 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 272,882 | $10.76 | $2,936,210.32 |
DisclosureSEC source: 0001209191-16-154272 · doc4.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,741,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 19:37 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 527,118 | $0.00 Strike: $10.76 | $0.00 |
DisclosureSEC source: 0001209191-16-154256 · doc4.xml · derivative · entry 5 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,882 Underlying: Common Shares · 527,118 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of April 30, 2013, the vesting commencement date. F6 · balance_after: Dr. Sehat Sutardja is the husband of Ms. Weili Dai. Dr. Sutardja holds this option in his own name. Ms. Weili Dai may be deemed to be an indirect beneficial owner of this option. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 19:37 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 527,118 | $14.11 | $7,435,473.80 |
DisclosureSEC source: 0001209191-16-154256 · doc4.xml · nonDerivative · entry 2 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.07 to $14.185, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 19:37 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 527,118 | $10.76 | $5,671,789.68 |
DisclosureSEC source: 0001209191-16-154256 · doc4.xml · nonDerivative · entry 1 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,996,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $12.92 | $0.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · derivative · entry 17 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 100,000 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of June 10, 2009, the vesting commencement date. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $10.76 | $0.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · derivative · entry 16 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 300,000 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of April 30, 2013, the vesting commencement date. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $10.76 | $0.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · derivative · entry 15 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Shares · 200,000 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of April 30, 2013, the vesting commencement date. F8 · balance_after: Dr. Sehat Sutardja is the husband of Ms. Weili Dai. Dr. Sutardja holds this option in his own name. Ms. Weili Dai may be deemed to be an indirect beneficial owner of this option. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · derivative · entry 14 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 300,000 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 15, 2008, the vesting commencement date. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 29,332 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · derivative · entry 13 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 29,332 shares Expires 2016-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option vests at the rate of 1/4th of the shares annually beginning on the first anniversary of December 15, 2008, the vesting commencement date. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 100,000 | $14.03 | $1,402,660.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 10 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.085, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 100,000 | $12.92 | $1,292,000.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 9 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,568,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 300,000 | $14.03 | $4,207,980.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 8 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.085, inclusive. The reporting person undertakes to provide Marvell Technology Group Ltd. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | Exercise / conversionCommon Shares | 300,000 | $10.76 | $3,228,000.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 7 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,768,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:42 UTC | MARVELL TECHNOLOGY GROUP LTD MRVL · Entity 140170 | SaleCommon Shares | 200,000 | $14.03 | $2,805,140.00 |
DisclosureSEC source: 0001209191-16-153913 · doc4.xml · nonDerivative · entry 6 Sutardja, Sehat · CIK 0001134141 · 10% owner Dai, Weili · CIK 0001134140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468,895 F1 · balance_after: These securities are jointly owned by Ms. Weili Dai and Dr. Sehat Sutardja who are members of a "Group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Dr. Sutardja and Ms. Dai are husband and wife. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.